23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia vs Invitae Genetic Testing

23andMe offers a direct-to-consumer model with an at-home saliva collection kit, making it highly accessible and convenient for users. Invitae, while offering an online portal for ordering and viewing reports, generally requires a healthcare provider to order tests, which adds a step to the user journey.

Invitae provides comprehensive genetic testing across many medical specialties with AI-powered interpretation and includes genetic counseling services, offering a broader and deeper clinical utility. 23andMe's Hereditary Thrombophilia test focuses on two specific genetic variants and is primarily for personal genetic insights to inform discussions with healthcare professionals, rather than comprehensive diagnostic testing. Invitae's tests have also been validated with high sensitivity and specificity for detecting deletions and duplications in genes across various conditions.

Invitae offers flexible billing options, including insurance coverage for most tests, with typical patient out-of-pocket costs ranging from $0-$100, and a pre-pay option of $250 per clinical area. They also have financial assistance programs and sponsored no-charge testing for eligible patients. 23andMe's specific Hereditary Thrombophilia test is part of their Health + Ancestry Service priced at $199, and is generally not covered by insurance.

Invitae is part of Labcorp, indicating a strong enterprise infrastructure and broad reach through Labcorp's nationwide patient service centers. They are HIPAA compliant and offer a Business Associate Agreement (BAA), which are crucial for enterprise healthcare integrations. 23andMe does not offer a BAA and is not HIPAA compliant, limiting its readiness for direct enterprise healthcare system integration.

Invitae leverages AI-powered interpretation for variant classification and offers comprehensive multi-gene panel testing, including RNA analysis to supplement DNA results, which can provide more definitive results for complex cases. 23andMe's innovation lies in its direct-to-consumer model and FDA clearance for specific genetic health risk reports, but its testing for hereditary thrombophilia focuses on a limited number of common variants.

Invitae provides extensive support, including genetic counseling services at no additional cost in the US, US territories, and Canada, as well as dedicated client services and clinical practice resources for healthcare providers. 23andMe offers educational resources and customer care, but explicitly states that its screening does not include genetic counseling.